date,title,source
Nov-13-18,Novus Therapeutics Reports Third Quarter 2018 Financial Results,Business Wire
Nov-15-18,Novus Therapeutics to Present at the 2018 Piper Jaffray Healthcare Conference,Business Wire
Nov-27-18,Novus Therapeutics Doses First Subjects in Phase 1 Study of OP0201,Business Wire
Dec-04-18,Novus Therapeutics Announces Formation of Scientific Advisory Board,Business Wire
Dec-25-18,"Can We See Significant Institutional Ownership On The Novus Therapeutics, Inc. (NASDAQ:NVUS) Share Register?",Simply Wall St.
Jan-08-19,Novus Therapeutics Doses First Patient with Acute Otitis Media in Phase 1 Study of OP0201,Business Wire
